NFKB1 and Sjogren syndrome: As it has been established that RKIP is a negative regulator of NF-κB signalling, one study showed that RKIP deletion significantly activated the NF-κB pathway and induced inflammatory cytokines and chemokines to be released in primary Sjögren syndrome [135].